• 129 Citations
  • 5 h-Index
20152020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 129 Citations
  • 5 h-Index
  • 14 Article
Filter
Article
2020

Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma

Ishikawa, M., Hayashi, H., Sakamoto, N., Tanaka, S. & Nishihara, H., 2020 Jan 1, In : Medical Oncology. 37, 1, 10.

Research output: Contribution to journalArticle

Intratumoral genomic heterogeneity may hinder precision medicine strategies in patients with serous ovarian carcinoma

Nakamura, K., Aimono, E., Tanishima, S., Imai, M., Nagatsuma, A. K., Hayashi, H., Yoshimura, Y., Nakayama, K., Kyo, S. & Nishihara, H., 2020 Apr, In : Diagnostics. 10, 4, 200.

Research output: Contribution to journalArticle

Open Access
2019

Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX

Shirasu, H., Todaka, A., Omae, K., Fujii, H., Mizuno, N., Ozaka, M., Ueno, H., Kobayashi, S., Uesugi, K., Kobayashi, N., Hayashi, H., Sudo, K., Okano, N., Horita, Y., Kamei, K., Yukisawa, S., Kobayashi, M. & Fukutomi, A., 2019 Feb 1, In : Cancer science. 110, 2, p. 707-716 10 p.

Research output: Contribution to journalArticle

Open Access
3 Citations (Scopus)
2018

Effectiveness of indocyanine green fluorescence in endoscopic marking in gastric cancer surgery: A feasibility study for replacing India ink

Ono, H., Kusano, M., Nihei, M., Hayashi, H., Fukushima, H., Kawakami, M., Danjo, Y., Nagashima, K., Shimizu, Y., Kawamata, F., Honda, S., Shimamura, T. & Nishihara, H., 2018 Jan 1, In : Journal of Japanese Society of Gastroenterology. 115, 4, p. 385-393 9 p.

Research output: Contribution to journalArticle

Genomic testing for pancreatic cancer in clinical practice as real-world evidence

Hayashi, H., Tanishima, S., Fujii, K., Mori, R., Okamura, Y., Yanagita, E., Matsuoka, R., Amano, T., Kinoshita, I., Komatsu, Y., Dosaka-Akita, H. & Nishihara, H., 2018 Sep 1, In : Pancreatology. 18, 6, p. 647-654 8 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

HGCSG 1403: phase I trial of oxaliplatin /irinotecan /S-1 (OX-IRIS) for unresectable pancreatic cancer

Kawamoto, Y., Yuki, S., Hayashi, H., Nakano, S., Sawada, K., Muranaka, T., Nakatsumi, H., Saiki, T., Ishiguro, A., Harada, K., Kobayashi, Y., Iwanaga, I., Hatanaka, K., Sakata, Y., Sakamoto, N. & Komatsu, Y., 2018 Oct, In : Annals of Oncology. 29, p. vii63

Research output: Contribution to journalArticle

Open Access

Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan

Todaka, A., Mizuno, N., Ozaka, M., Ueno, H., Kobayashi, S., Uesugi, K., Kobayashi, N., Hayashi, H., Sudo, K., Okano, N., Horita, Y., Kamei, K., Yukisawa, S., Nakamori, S., Yachi, Y., Henmi, T., Kobayashi, M., Boku, N., Mori, K. & Fukutomi, A., 2018 May 1, In : Pancreas. 47, 5, p. 631-636 6 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2017

An oncogenic ALK fusion and an rras mutation in KRAS mutation-negative pancreatic ductal adenocarcinoma

Shimada, Y., Kohno, T., Ueno, H., Ino, Y., Hayashi, H., Nakaoku, T., Sakamoto, Y., Kondo, S., Morizane, C., Shimada, K., Okusaka, T. & Hiraoka, N., 2017 Feb 6, In : Oncologist. 22, 2, p. 158-164 7 p.

Research output: Contribution to journalArticle

Open Access
8 Citations (Scopus)

Clinical Sequencing for Patients with Pancreatic Cancer

Hayashi, H., Tanishima, S., Mori, R., Okamura, Y., Amano, T., Kinoshita, I., Komatsu, Y., Dosaka-akita, H. & Nishihara, H., 2017 Oct, In : Annals of Oncology. 28, p. ix88

Research output: Contribution to journalArticle

Open Access

Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma

Kato, M., Nishihara, H., Hayashi, H., Kimura, T., Ishida, Y., Wang, L., Tsuda, M., Tanino, M. A. & Tanaka, S., 2017 Jan 1, In : Medical Oncology. 34, 1, 8.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Utility of assessing the number of mutated KRAS, CDKN2A, TP53, and SMAD4 genes using a targeted deep sequencing assay as a prognostic biomarker for pancreatic cancer

Hayashi, H., Kohno, T., Ueno, H., Hiraoka, N., Kondo, S., Saito, M., Shimada, Y., Ichikawa, H., Kato, M., Shibata, T., Morizane, C., Sakamoto, Y., Shimada, K., Komatsu, Y., Sakamoto, N. & Okusaka, T., 2017 Mar 1, In : Pancreas. 46, 3, p. 335-340 6 p.

Research output: Contribution to journalArticle

21 Citations (Scopus)
2016

A novel treatment strategy for pancreatic cancer based on gene profiles

Hayashi, H. & Nishihara, H., 2016 Nov 1, In : Japanese Journal of Cancer and Chemotherapy. 43, 11, p. 1326-1331 6 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Cytomegalovirus colitis in a patient undergoing postoperative adjuvant chemotherapy for lung adenocarcinoma with uracil-tegafur

Hayashi, H., Komatsu, Y., Uchida, T., Abe, N., Ito, K., Hirata, K., Matsuda, K. & Fujinaga, A., 2016 Dec 1, In : Journal of Infection and Chemotherapy. 22, 12, p. 826-829 4 p.

Research output: Contribution to journalArticle

2015

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer

Takai, E., Totoki, Y., Nakamura, H., Morizane, C., Nara, S., Hama, N., Suzuki, M., Furukawa, E., Kato, M., Hayashi, H., Kohno, T., Ueno, H., Shimada, K., Okusaka, T., Nakagama, H., Shibata, T. & Yachida, S., 2015 Dec 16, In : Scientific reports. 5, 18425.

Research output: Contribution to journalArticle

Open Access
76 Citations (Scopus)